Search research articles
Contact Us
Filters
Showing results (1-10 of 13) with videos related to
Page
of 2
Sort By:
Antonie Van Leeuwenhoek
|
June 16, 2025
Siderophores produced by marine microorganisms
Lei Chen, Zhuo-Yue Li, Guang-Yu Wang
Drug Delivery
|
July 28, 2021
Effect of XlogP and hansen solubility parameters on the prediction of small molecule modified docetaxel, doxorubicin and irinotecan conjugates forming stable nanoparticles
Mei-Qi Xu, Ting Zhong, Xin Yao, et al.
Materials (Basel, Switzerland)
|
October 14, 2022
Multifunctional Coding-Feeding Metasurface Based on Phase Manipulation
Guo-Shuai Huang, Si-Jia Li, Zhuo-Yue Li, et al.
Optics Express
|
October 14, 2022
Transmissive coding metasurface with dual-circularly polarized multi-beam
Si Jia Li, Bo Wen Han, Zhuo Yue Li, et al.
Biomaterials Science
|
April 17, 2026
Targeting and self-assembling peptides mimic fibrinogen coagulation for alleviating hypofibrinogenemia
Gui-Yuan Wang, Zhuo-Yue Li, Chao-Ran Li, et al.
International Journal of Nanomedicine
|
November 5, 2021
Antitumor Activity of α-Linolenic Acid-Paclitaxel Conjugate Nanoparticles: In vitro and in vivo
Mei-Qi Xu, Yan-Li Hao, Jing-Ru Wang, et al.
Acta Biomaterialia
|
October 7, 2021
A combination strategy based on an Au nanorod/doxorubicin gel via mild photothermal therapy combined with antigen-capturing liposomes and anti-PD-L1 agent promote a positive shift in the cancer-immunity cycle
Zhen-Han Feng, Zhan-Tao Li, Shuang Zhang, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society
|
December 25, 2018
Anti-tumour activity of low molecular weight heparin doxorubicin nanoparticles for histone H1 high-expressive prostate cancer PC-3M cells
Shuang Zhang, Zhan-Tao Li, Man Liu, et al.
International Journal of Nanomedicine
|
March 22, 2018
The theranostic efficiency of tumor-specific, pH-responsive, peptide-modified, liposome-containing paclitaxel and superparamagnetic iron oxide nanoparticles
Xiu-Chai Zheng, Wei Ren, Shuang Zhang, et al.
International Journal of Nanomedicine
|
January 15, 2019
Antitumor activity of the bioreductive prodrug 3-(2-nitrophenyl) propionic acid-paclitaxel nanoparticles (NPPA-PTX NPs) on MDA-MB-231 cells: in vitro and in vivo
Xiao-Chuan Duan, Xin Yao, Shuang Zhang, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 13) with videos related to
Sort By:
Page
of 2
Antonie Van Leeuwenhoek
|
June 16, 2025
Siderophores produced by marine microorganisms
Lei Chen, Zhuo-Yue Li, Guang-Yu Wang
Drug Delivery
|
July 28, 2021
Effect of XlogP and hansen solubility parameters on the prediction of small molecule modified docetaxel, doxorubicin and irinotecan conjugates forming stable nanoparticles
Mei-Qi Xu, Ting Zhong, Xin Yao, et al.
Materials (Basel, Switzerland)
|
October 14, 2022
Multifunctional Coding-Feeding Metasurface Based on Phase Manipulation
Guo-Shuai Huang, Si-Jia Li, Zhuo-Yue Li, et al.
Optics Express
|
October 14, 2022
Transmissive coding metasurface with dual-circularly polarized multi-beam
Si Jia Li, Bo Wen Han, Zhuo Yue Li, et al.
Biomaterials Science
|
April 17, 2026
Targeting and self-assembling peptides mimic fibrinogen coagulation for alleviating hypofibrinogenemia
Gui-Yuan Wang, Zhuo-Yue Li, Chao-Ran Li, et al.
International Journal of Nanomedicine
|
November 5, 2021
Antitumor Activity of α-Linolenic Acid-Paclitaxel Conjugate Nanoparticles: In vitro and in vivo
Mei-Qi Xu, Yan-Li Hao, Jing-Ru Wang, et al.
Acta Biomaterialia
|
October 7, 2021
A combination strategy based on an Au nanorod/doxorubicin gel via mild photothermal therapy combined with antigen-capturing liposomes and anti-PD-L1 agent promote a positive shift in the cancer-immunity cycle
Zhen-Han Feng, Zhan-Tao Li, Shuang Zhang, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society
|
December 25, 2018
Anti-tumour activity of low molecular weight heparin doxorubicin nanoparticles for histone H1 high-expressive prostate cancer PC-3M cells
Shuang Zhang, Zhan-Tao Li, Man Liu, et al.
International Journal of Nanomedicine
|
March 22, 2018
The theranostic efficiency of tumor-specific, pH-responsive, peptide-modified, liposome-containing paclitaxel and superparamagnetic iron oxide nanoparticles
Xiu-Chai Zheng, Wei Ren, Shuang Zhang, et al.
International Journal of Nanomedicine
|
January 15, 2019
Antitumor activity of the bioreductive prodrug 3-(2-nitrophenyl) propionic acid-paclitaxel nanoparticles (NPPA-PTX NPs) on MDA-MB-231 cells: in vitro and in vivo
Xiao-Chuan Duan, Xin Yao, Shuang Zhang, et al.
Page
of 2